A novel histone deacetylase inhibitor, CKD5, has potent anti-cancer effects in glioblastoma.

about

Trichostatin A Sensitizes Hepatocellular Carcinoma Cells to Enhanced NK Cell-mediated Killing by Regulating Immune-related Genes.The p53 Pathway in Glioblastoma

P2860

Q41664041-0E48A0E4-A053-44ED-B945-BCA8CE77B0A1 Q57162865-3D6479BC-F7CA-44D9-9D27-90F4364DBA7A

P2860

A novel histone deacetylase inhibitor, CKD5, has potent anti-cancer effects in glioblastoma.

Item

http://www.wikidata.org/entity/Q37705920

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

A novel histone deacetylase in ...... ancer effects in glioblastoma.

@en

A novel histone deacetylase in ...... ancer effects in glioblastoma.

@nl

type

Item

label

A novel histone deacetylase in ...... ancer effects in glioblastoma.

@en

A novel histone deacetylase in ...... ancer effects in glioblastoma.

@nl

prefLabel

A novel histone deacetylase in ...... ancer effects in glioblastoma.

@en

A novel histone deacetylase in ...... ancer effects in glioblastoma.

@nl

P1476

A novel histone deacetylase in ...... ancer effects in glioblastoma.

@en

P2093

Chang Sik Lee

http://www.w3.org/2001/XMLSchema#string

Chul-Kee Park

http://www.w3.org/2001/XMLSchema#string

Ji Hoon Phi

http://www.w3.org/2001/XMLSchema#string

Ji Yeoun Lee

http://www.w3.org/2001/XMLSchema#string

Ju-Hee Lee

http://www.w3.org/2001/XMLSchema#string

Kyu-Chang Wang

http://www.w3.org/2001/XMLSchema#string

Pil Ae Kwak

http://www.w3.org/2001/XMLSchema#string

Seung Ah Choi

http://www.w3.org/2001/XMLSchema#string

Seung-Ki Kim

http://www.w3.org/2001/XMLSchema#string

P2860

The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin.

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

Malignant gliomas in adults

Novel modified method for injection into the cerebrospinal fluid via the cerebellomedullary cistern in mice.

Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study.

Vorinostat in solid and hematologic malignancies

Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study

Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study.

Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial.

P304

9123-9133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.13265

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27852054

http://www.w3.org/2001/XMLSchema#string

P932

5354719

http://www.w3.org/2001/XMLSchema#string

A novel histone deacetylase inhibitor, CKD5, has potent anti-cancer effects in glioblastoma.

about

P2860

P2860

A novel histone deacetylase inhibitor, CKD5, has potent anti-cancer effects in glioblastoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932